This M&A case requires candidates to evaluate three acquisition targets across multiple dimensions (strategic fit, economics, and risk). The case tests quantitative analysis skills through financial modeling of synergies and overlap impacts, combined with qualitative assessment of integration complexity and market opportunity.
Your client is Animal Pharma, a public pharmaceutical supplier focused on oral solid medications (e.g., tablets, capsules).
Animal Pharma’s portfolio has been impacted by decreasing margins.
Animal Pharma is considering the acquisition of a rival supplier to boost profitability.
Animal Pharma’s CEO has hired you to review the attractiveness of this strategy.